PT Indo Acidatama Tbk (SRSN) Stock Analysis 2026: Is This Indonesian Ethanol Stock Worth Watching?
 |
| PT Indo Acidatama Tbk (SRSN) |
Worldreview1989 - PT Indo Acidatama Tbk (IDX: SRSN) is a small-cap Indonesian chemical manufacturer that may be unfamiliar to many U.S. investors. However, the company has an interesting business model: it produces ethanol, acetic acid, and other agrochemical-related products, with ethanol accounting for the overwhelming majority of its revenue.
For investors accustomed to analyzing U.S. stocks, SRSN is particularly interesting because its 2025–2026 financial results show a sharp improvement in profitability despite relatively modest revenue growth.
The bigger question is whether that earnings improvement is sustainable.
Based on the latest available first-half 2026 financial statements, SRSN generated Rp557.6 billion of revenue and Rp72.1 billion of net income, while net income increased approximately 191% year over year. At the same time, total debt had fallen dramatically compared with year-end 2025.
This article examines SRSN from the perspective of a U.S.-style value investor, focusing on earnings quality, margins, valuation, balance-sheet strength, business concentration, and the risks that investors should understand before buying the stock.
Important: This is an educational analysis, not personalized investment advice. SRSN is an Indonesian-listed small-cap stock and may have substantially different liquidity and risk characteristics from large U.S. equities.
What Is PT Indo Acidatama Tbk?
PT Indo Acidatama Tbk is an Indonesian agrochemical and chemical manufacturer. The company traces its history to 1982 and was originally established as PT Sarasa Nugraha Tbk before becoming PT Indo Acidatama Tbk. Its shares have been publicly traded since 1992.
The company's primary products include:
Ethanol
Acetic acid
Molasses
Fertilizer
CO₂
Spiritus
Other chemical/agrochemical products
The company's own corporate materials describe it as an international-standard Indonesian agrochemical producer and identify ethanol as a major product.
One particularly interesting feature is its integrated ethanol and acetic-acid production.
The company states that it produces food-grade acetic acid with approximately 99.8% purity and describes itself as the first and only integrated acetic-acid producer in Indonesia and Southeast Asia.
Why Does Ethanol Matter So Much?
Ethanol represented approximately 84.8% of SRSN's 2025 revenue.
According to the audited 2025 financial statements:
| 2025 Segment | Revenue |
|---|---|
| Ethanol | Rp1.066 trillion |
| Acetic Acid | Rp89.65 billion |
| Other Products | Rp100.70 billion |
| Total | Rp1.256 trillion |
Ethanol therefore dominates the company's economics.
This creates both an opportunity and a risk.
If ethanol pricing, volume, or margins improve, SRSN can experience substantial earnings growth. But if ethanol prices or margins deteriorate, the company's profitability could fall quickly.
SRSN Financial Performance: 2025
The most important development in SRSN's recent history is the dramatic improvement in profitability during 2025.
According to the company's 2025 financial statements, revenue increased from approximately Rp1.154 trillion in 2024 to Rp1.256 trillion in 2025, an increase of about 8.9%.
But net income increased much faster:
Rp22.5 billion → Rp77.4 billion
That's approximately 244% year-over-year growth.
2024 vs. 2025
| Metric | 2024 | 2025 | Change |
|---|---|---|---|
| Revenue | Rp1.154T | Rp1.256T | +8.9% |
| Gross Profit | Rp191.7B | Rp312.1B | +62.8% |
| EBITDA | Rp50.5B | Rp126.8B | +151.1% |
| Net Income | Rp22.5B | Rp77.4B | +244.0% |
| Net Margin | ~2.0% | ~6.2% | Significant improvement |
This is a very important pattern.
Revenue grew only moderately, while gross profit and net income grew dramatically.
For a value investor, this is potentially more interesting than simple revenue growth.
It suggests that operating leverage, product margins, cost structure, pricing, or some combination of these factors materially improved during 2025.
First-Half 2026: The Profit Improvement Continued
The latest available financial information makes the story even more interesting.
During the first six months of 2026, SRSN reported:
Revenue: Rp557.6 billion
Gross profit: Rp166.3 billion
EBITDA: Rp91.5 billion
Net income: Rp72.1 billion
Compared with the first half of 2025:
Revenue declined approximately 9.5%
Gross profit increased approximately 32.1%
EBITDA increased approximately 95.9%
Net income increased approximately 190.7%
This is arguably the most important data point for investors.
Revenue Down, Profit Up
At first glance, a 9.5% decline in revenue appears negative.
But SRSN simultaneously increased gross profit by more than 32% and net income by more than 190%.
That means the company is currently demonstrating a substantial improvement in profitability per rupiah of sales.
The first-half 2026 net margin was approximately:
Rp72.1B ÷ Rp557.6B = 12.9%
That compares with approximately 4.0% during the first half of 2025 based on the reported figures.
This is an extraordinary improvement.
The Margin Story Is More Important Than Revenue Growth
For investors analyzing SRSN, I would focus less on revenue growth and more on margin sustainability.
The company reported:
| Margin | FY2025 | 1H2026 |
|---|---|---|
| Gross Margin | 24.8% | 29.8% |
| EBITDA Margin | 10.1% | 16.4% |
| Net Margin | 6.2% | 12.9% |
This suggests that SRSN has entered a significantly more profitable operating environment.
But investors should not automatically extrapolate a 12.9% net margin indefinitely.
Small commodity and chemical manufacturers can experience significant swings in:
Raw-material prices
Selling prices
Energy costs
Export demand
Foreign-exchange rates
Production utilization
Government regulations
Working-capital requirements
Therefore, the key investment question is:
Can SRSN maintain a structurally higher margin, or was 2026 an unusually favorable period?
Balance Sheet Analysis
The balance sheet has also improved substantially.
At the end of 2025, SRSN reported:
Total assets: approximately Rp1.052 trillion
Total equity: approximately Rp809.8 billion
Short-term debt: approximately Rp217.9 billion
Long-term debt: approximately Rp24.7 billion
Cash: approximately Rp6.3 billion
By June 2026, reported figures were:
Total assets: approximately Rp1.013 trillion
Total equity: approximately Rp875.3 billion
Total debt: approximately Rp14.1 billion
Cash: approximately Rp32.0 billion
This is one of the strongest parts of the current SRSN investment case.
Total debt declined dramatically from the 2025 level.
StockAnalysis' historical data also shows total debt falling from approximately Rp109.9 billion at year-end 2025 to Rp14.1 billion by June 2026, while cash increased to approximately Rp32 billion.
Why This Matters
A company generating more profit while simultaneously reducing debt is generally in a healthier financial position than a company generating the same profit by borrowing aggressively.
The reduction in leverage potentially gives SRSN:
Lower interest expense
Greater financial flexibility
Lower refinancing risk
Greater resilience during industry downturns
More capacity for future capital expenditure or dividends
SRSN Valuation
Valuation is where SRSN becomes particularly interesting.
At a reported share price of approximately Rp69, the company had a market capitalization of roughly Rp415 billion in the second-quarter 2026 financial snapshot.
The reported valuation metrics included:
P/E: ~5.76x
P/B: ~0.47x
EPS: Rp11.97
BVPS: Rp145.39
ROA: ~7.12%
ROE: ~8.23%
EV/EBITDA: ~4.29x
Debt/Equity: ~0.01x
From a pure valuation perspective, these numbers look inexpensive.
A price-to-book ratio below 0.5x means the market value of the company was less than half of its reported book value at the cited price.
The trailing P/E was also below 6x based on the cited financial snapshot.
However, low valuation does not automatically mean a stock is undervalued.
A stock can remain cheap for years if:
Earnings are cyclical
Liquidity is low
Growth is limited
Minority shareholders have concerns
Corporate governance is perceived as weak
Investors cannot confidently forecast future earnings
This is why SRSN should be viewed as a small-cap value/cyclical opportunity, rather than simply a "cheap stock."
What U.S. Investors Might Like About SRSN
If American investors approached SRSN using a traditional fundamental-analysis framework, several characteristics could attract attention.
1. Very Low Valuation
A P/E below 6x and P/B below 0.5x are inexpensive by conventional equity-market standards.
The market is clearly not assigning a high growth multiple to SRSN.
2. Strong Earnings Momentum
The company increased 2025 net income approximately 244% year over year.
Then, during the first half of 2026, net income increased another approximately 191% year over year.
3. Debt Reduction
The dramatic reduction in debt during the first half of 2026 materially strengthens the balance sheet.
4. High Exposure to Ethanol
Ethanol isn't a minor side business.
It is the company's core business and generated more than Rp1 trillion of revenue during 2025.
That gives investors a relatively clear thesis: monitor the economics of ethanol and the company's production margins.
5. Integrated Production
The integration between ethanol and acetic acid creates a differentiated industrial business model.
The company uses molasses from sugar production as a raw material for ethanol production.
The 2025 financial statements also show the company had molasses purchase contracts totaling 124,000 tons for 2025, compared with 119,450 tons in 2024.
What Could Go Wrong?
A serious stock analysis must also examine the bear case.
1. Ethanol Concentration Risk
Approximately 85% of 2025 revenue came from ethanol.
That creates concentration risk.
If ethanol prices decline substantially or raw-material costs rise, SRSN's margins could contract.
2. Commodity-Like Economics
Although SRSN manufactures industrial chemicals, several of its products are influenced by commodity economics.
Investors should monitor:
Molasses prices
Energy costs
Ethanol selling prices
Domestic demand
Export demand
Currency movements
3. Small-Cap Liquidity Risk
SRSN is not comparable to large U.S. companies such as Exxon Mobil, Dow, or Linde.
Its relatively small market capitalization means investors should pay close attention to trading liquidity and bid-ask spreads.
A stock can look cheap on paper while still being difficult to buy or sell at a desired price.
4. Earnings Sustainability
The largest question is whether the enormous increase in net profit represents a permanent improvement.
If net margin returns toward historical levels, today's P/E could be misleading.
This is why investors should compare:
normalized earnings vs. reported earnings.
5. Revenue Decline in 1H2026
Although profitability improved significantly, first-half 2026 revenue declined approximately 9.5% year over year.
That divergence deserves attention.
If revenue continues declining while margins remain elevated, the market may eventually question whether the current profitability is sustainable.
Dividend Analysis
SRSN has historically paid cash dividends, although the dividend is not the primary attraction of the stock.
The 2025 financial statements disclose cash dividend payments of approximately Rp6.017 billion during 2025.
Compared with the approximately Rp77.4 billion of 2025 net income, that represents a relatively modest portion of earnings.
For investors, this suggests the company has historically retained a substantial amount of its earnings rather than distributing most profits to shareholders.
That could be positive if retained earnings are invested productively.
However, investors should monitor future capital allocation closely.
A Simple SRSN Valuation Scenario
Instead of predicting a single target price, it is more useful to create scenarios.
Assume normalized EPS of approximately Rp10–Rp12.
Bear Case
If investors assign only a 4x P/E multiple:
Rp10 × 4 = Rp40
Base Case
If normalized EPS reaches Rp12 and the market assigns 6x:
Rp12 × 6 = Rp72
Bull Case
If EPS reaches Rp15 and the market assigns 8x:
Rp15 × 8 = Rp120
These are illustrative valuation scenarios, not price targets.
The biggest variable is not the P/E multiple.
It is normalized EPS.
If SRSN can maintain the stronger profitability demonstrated during 2026, the current valuation may look unusually low.
If margins normalize sharply downward, the apparent cheapness could disappear.
What Should Investors Watch in the Next Financial Reports?
For anyone considering SRSN, I would monitor these seven indicators every quarter.
1. Ethanol Revenue
Does ethanol revenue continue to grow?
2. Gross Margin
Can SRSN maintain a gross margin near 30%?
3. EBITDA Margin
Can the company maintain an EBITDA margin above 15%?
4. Net Income
Is earnings growth still coming from genuine operating performance?
5. Debt
Does the company remain close to a net-cash position?
6. Operating Cash Flow
This is extremely important.
Accounting earnings should eventually translate into cash generation.
7. Capital Allocation
Watch whether management:
Reinvests in profitable capacity
Pays dividends
Reduces debt
Makes acquisitions
Builds excessive working capital
My Fundamental View on SRSN
From a fundamental perspective, SRSN has become significantly more interesting during 2026.
The combination of:
low valuation + rising profitability + debt reduction
creates a compelling value-investing setup.
The strongest evidence is the contrast between revenue and earnings.
Revenue declined 9.5% in the first half of 2026, but net income increased approximately 191%.
That tells us that the company's economics have changed materially.
However, I would not classify SRSN as a conventional "buy and forget" stock.
Instead, it is better viewed as a small-cap industrial/value stock that requires quarterly monitoring.
The central investment thesis is:
If SRSN can sustain its improved margins and maintain its much lower debt burden, the stock appears inexpensive relative to its current earnings power.
The central bear thesis is:
If the 2025–2026 margin expansion proves temporary, today's low P/E may be less attractive than it appears.
SRSN Investment Scorecard
| Category | Assessment |
|---|---|
| Revenue Growth | ⭐⭐⭐ |
| Profit Growth | ⭐⭐⭐⭐⭐ |
| Gross Margin Trend | ⭐⭐⭐⭐⭐ |
| Balance Sheet | ⭐⭐⭐⭐⭐ |
| Debt Reduction | ⭐⭐⭐⭐⭐ |
| Valuation | ⭐⭐⭐⭐⭐ |
| Dividend Appeal | ⭐⭐⭐ |
| Business Diversification | ⭐⭐ |
| Earnings Predictability | ⭐⭐⭐ |
| Small-Cap Risk | ⭐⭐ |
| Overall Fundamental Potential | 4/5 |
Final Verdict: Is SRSN Stock Worth Watching?
Yes — particularly for value-oriented investors.
PT Indo Acidatama Tbk currently offers an unusual combination of characteristics:
A market capitalization of roughly Rp400 billion at the cited 2026 price
P/E below 6x based on the June 2026 financial snapshot
P/B below 0.5x
Rapid earnings growth
Strong margin expansion
Dramatically lower debt
A large ethanol business
A differentiated acetic-acid operation
The major issue is earnings quality and sustainability.
A sophisticated investor should therefore avoid asking only:
"Is SRSN cheap?"
The better question is:
"What level of earnings can SRSN sustainably generate over the next three to five years?"
If normalized earnings remain close to the company's improved 2026 performance, the valuation could be attractive.
If earnings revert toward the weaker margins seen before 2025, the stock may deserve its discounted valuation.
For that reason, SRSN is best categorized as a speculative value opportunity rather than a low-risk compounder.
Primary and Credible References
PT Indo Acidatama Tbk – Investor Relations — the company's official investor-relations page provides its 2025 annual report, financial statements, 2026 interim financial statements, AGM materials, and corporate disclosures.
PT Indo Acidatama Investor RelationsPT Indo Acidatama Tbk – 2025 Financial Statements — audited financial information including revenue, segment performance, debt, assets, equity, dividends, and sales by product.
PT Indo Acidatama Tbk – 1H 2026 Financial Statements — latest financial information used in this analysis.
PT Indo Acidatama Tbk – Ethanol Product Information — company information concerning ethanol production, applications, and raw materials.
PT Indo Acidatama Tbk – Acetic Acid Product Information — company information concerning acetic-acid production and applications.
Otoritas Jasa Keuangan (OJK) — investor education emphasizing that investors should understand risk and perform appropriate analysis rather than chase speculative price movements.
Bottom Line
SRSN is not a typical high-growth stock. It is a small Indonesian industrial/value stock whose investment case has improved because profitability has risen dramatically while leverage has fallen.
For a U.S.-style investor, the most attractive feature is not simply the low P/E.
It is the possibility that the market has not yet fully recognized the company's improved earnings power.
The next quarterly reports will therefore be crucial. If margins remain strong, debt stays low, and operating cash flow confirms the earnings, the valuation case becomes substantially stronger. If margins fall sharply, investors should assume that the 2026 earnings surge was at least partly cyclical.
Investment characterization: Value / Small-Cap / Cyclical / Higher Risk
Not a recommendation to buy or sell.
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks
Join Facebook Group